The current method of HPV screening is to do a direct examination of cervical secretions. For women, HPV infection mainly causes cervical intraepithelial neoplasia or cervical cancer in the cervix, while low-risk HPV infection also leads to localized genital warts, so instead of drawing venous blood, HPV screening is done directly on cervical secretions to confirm whether there is HPV infection. This is the time to do a quantitative HPVDNA test and also a HPV typing test, which is to confirm which type of HPV infection is present, and also to distinguish between high-risk and low-risk infections. This is because high-risk and low-risk infections affect women differently. For example, in the case of high-risk HPV infection, a TCT test is needed to rule out cervical intraepithelial neoplasia or cervical cancer, and even a colposcopic biopsy is needed to confirm the diagnosis. However, if the infection is low-risk HPV with cauliflower-like growths, the growths will usually need to be removed and sent for pathological examination to confirm the diagnosis of condyloma acuminata. The first thing you need to do is to do a direct cervical screening; if you have a positive result, you need to do a quantitative HPVDNA test or HPV typing test; if you have a high-risk HPV infection, you need to do a TCT test, if you have a low-risk type and a superfluous organism, you need to remove the superfluous organism for pathological examination.